Start Submission Become a Reviewer

Reading: Continuous subcutaneous insulin infusion versus multiple dose insulin

Download

A- A+
dyslexia friendly

Clinical Updates

Continuous subcutaneous insulin infusion versus multiple dose insulin

Authors:

Yashdeep Gupta ,

Government Medical College, Chandigarh, IN
About Yashdeep
Department of Medicine
X close

Sanjay Kalra

Bride Hospital, Karnal, IN
About Sanjay
Department of Endocrinology
X close

Abstract

Continuous subcutaneous insulin infusion (CSII), also known as insulin pump therapy and multiple dose insulin (MDI) are the two main intensified insulin regimens that have been used to achieve strict glycaemic control in patients with diabetes mellitus, especially with type 1 diabetes (T1DM). Each mode of therapy has its own merits and demerits. CSII is a costly and complex therapeutic intervention, but on the other hand provides flexibility, improves patient’s quality of life, glycaemic control and decreases hypoglycaemic episodes in certain situations. This review will summarize current evidence on CSII vs MDI on various outcomes. This will help health professionals to select the most appropriate method of insulin administration for the given situation.

DOI: http://dx.doi.org/10.4038/sjdem.v4i1.7249

Sri Lanka Journal of Diabetes, Endocrinology and Metabolism 2014; 4: 22-29

How to Cite: Gupta, Y. & Kalra, S., (2014). Continuous subcutaneous insulin infusion versus multiple dose insulin. Sri Lanka Journal of Diabetes Endocrinology and Metabolism. 4(1), pp.22–29. DOI: http://doi.org/10.4038/sjdem.v4i1.7249
Published on 03 Aug 2014.
Peer Reviewed

Downloads

  • PDF (EN)

    comments powered by Disqus